Biokey International Inc (BKYI)

[Gamco]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
February 3, 2016
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES ACT OF 1933
BIO-key International, Inc.
File No. 333-208747 - CF#33308
_____________________
BIO-key International, Inc. submitted an application under Rule 406 requesting
confidential treatment for information it excluded from the Exhibits to a Form S-1
registration statement filed on December 23, 2015.
Based on representations by BIO-key International, Inc. that this information
qualifies as confidential commercial or financial information under the Freedom of
Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined
not to publicly disclose it. Accordingly, excluded information from the following
exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.36 through December 22, 2025
For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:
Brent J. Fields
Secretary